DEF 14A: Talphera, Inc. Announces Annual Meeting of Stockholders and Proxy Proposals

Talphera, Inc. is holding its annual meeting of stockholders on June 24, 2024, to vote on director elections, auditor ratification, executive compensation, and equity incentive plan approvals.

Summary

• Talphera, Inc. will hold its Annual Meeting of Stockholders on June 24, 2024, virtually.
• Stockholders will vote on six proposals, including the election of two Class I directors, ratification of BPM LLP as the independent registered public accounting firm, an advisory vote on executive compensation, approval of the Amended and Restated 2020 Equity Incentive Plan, and approval of the Amended and Restated 2011 Employee Stock Purchase Plan.
• The record date for the Annual Meeting is April 26, 2024.
• The Board of Directors recommends voting FOR all proposals.
• The company is seeking stockholder approval to increase the number of shares available under the 2020 Equity Incentive Plan by 1,171,395 shares.
• The company is also seeking stockholder approval to increase the number of shares available under the 2011 Employee Stock Purchase Plan by 100,000 shares, bringing the total to 345,000 shares.
• The company changed its independent registered public accounting firm from WithumSmith+Brown, PC to BPM LLP on October 2, 2023.
• Stockholder proposals for the 2025 Annual Meeting must be submitted by December 30, 2024.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The company is seeking approval for routine matters, and the Board recommends voting in favor of all proposals. There are some mentions of past financial difficulties, but overall the document is informative and does not express strong positive or negative sentiment.

Positives

• The virtual format of the Annual Meeting enhances stockholder access by allowing participation from any location at no cost.
• The Amended 2020 Equity Incentive Plan includes provisions designed to protect stockholders' interests and reflect corporate governance best practices, such as requiring stockholder approval for additional shares and limiting non-employee director compensation.
• The company has adopted an executive compensation recovery policy, or clawback policy, regarding the adjustment or recovery of certain incentive awards or payments made to current or former executive officers in the event that we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws.

Negatives

• Withum's audit report for the fiscal year ended December 31, 2022, included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
• The company had a material weakness in its internal control over financial reporting related to earnings per share calculations during the fiscal year ended December 31, 2022, although it was remediated as of June 30, 2023.

Risks

• If the stockholders fail to ratify the selection of BPM LLP, the Board will reconsider whether or not to retain that firm.
• The company's ability to realize the benefit of any tax deductions depends on its generation of taxable income.
• The company's compensation committee recognizes the challenge of recruiting, motivating and retaining executive officers in an industry with much longer business cycles than other commercial industries, and evolving compensation governance and best practices.

Future Outlook

The Board believes that the Amended 2020 Plan is in the best interests of our business and our stockholders and recommends a vote in favor of this Proposal 4.

Management Comments

• Given the above-listed factors, we feel a virtual-only meeting is the right choice for Talphera and its stockholders at this time.
• Our Board and the Nominating and Corporate Governance Committee are committed to ensuring that the Board is comprised of a highly capable group of directors who collectively provide a significant breadth of experience, knowledge and ability to effectively represent the interest of stockholders, drive stockholder value and reflect our corporate values of integrity, honesty and adherence to high ethical standards.

Industry Context

The company operates in the biopharmaceutical and biotechnology industries, which are characterized by strong competition for highly trained and experienced individuals.

Comparison to Industry Standards

• The Compensation Committee generally targeted our named executive officers 2023 base salary, annual incentive bonuses and employee benefits elements of our executives compensation to be at or near the 50th percentile of our peer group, and the long-term equity incentive element of our executives compensation to be at or near the 50th to 75th percentile of our peer group based on a percent of company basis (i.e., the number of shares granted as a percent of total shares outstanding).
• Our non-employee director cash compensation is aligned with the 50th percentile of our peer group.

Management Changes

Corporate Governance

Related Party Transactions

• In January 2024, we entered into securities purchase agreements with certain institutional investors to which we issued in a private placement pre-funded warrants at a purchase price of $0.769 per share, to purchase up to an aggregate of 7,792,208 shares of common stock at an exercise price of $0.001 per share, for aggregate upfront gross proceeds of approximately $6.0 million, excluding proceeds, if any, from the exercise of the pre-funded warrants.
• Pursuant to the securities purchase agreements with Nantahala Capital Management, LLC and its affiliates (collectively, Nantahala), for so long as Nantahala beneficially own securities representing at least 10% of the voting power of all our common stock then outstanding (including for purposes of such calculation, assuming the exercise in full of any derivative securities then beneficially owned by Nantahala and not giving effect to any contractual prohibition on exercise contained therein), Nantahala shall have the right, subject to compliance with the applicable rules and regulations of The Nasdaq Global Market, to designate one member of our board of directors, or the Nantahala Board Representative.

Stakeholder Impact

• Approval of the equity incentive plans is intended to attract, retain, and motivate employees, directors, and consultants, aligning their interests with those of the stockholders.
• The advisory vote on executive compensation allows stockholders to express their views on the company's pay practices.
• The ratification of the independent registered public accounting firm ensures the integrity of the company's financial reporting.

Next Steps

• Stockholders are encouraged to vote on the proposals as soon as possible.
• The company will file a report on Form 8-K within four business days after the Annual Meeting to publish the final voting results.

Key Dates

Keywords

proxy statement, annual meeting, stockholders, equity incentive plan, executive compensation, directors, BPM LLP, voting, Talphera